Biliary Atresia: Clinical Trials

2 trials for Biliary Atresia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 2 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 12Completed 1, Recruiting 1

Follow Biliary Atresia: new trials by email Literature Review of Biliary Atresia trials Research Report on Biliary Atresia

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Use of Near-Infrared Fluorescence Cholangiography With Indocyanine Green (ICG) in the Work Up of Neonatal Cholestasis
Indocyanine Green - Biliary Atresia, Kasai
Early Phase 1RecruitingUniversity of Alabama at Birmingham152026-01-232026-02-18
GCSF Adjunct Therapy for Biliary Atresia
Granulocyte Colony-Stimulating Factor - Biliary Atresia
Early Phase 1CompletedHolterman, Ai-Xuan, M.D.62018-01-152020-02-17

Narrower conditions

Cholestasis (1)

Broader conditions

Bile Duct Diseases (2)  ·  Biliary Tract Diseases (2)  ·  Congenital Abnormalities (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Digestive System Abnormalities (2)  ·  Digestive System Diseases (2)

Interventions

Filgrastim (1)  ·  Granulocyte Colony-Stimulating Factor (1)  ·  Indocyanine Green (1)

Sponsors

Holterman, Ai-Xuan, M.D. (1)  ·  University of Alabama at Birmingham (1)

Countries

United States (2)  ·  Vietnam (1)

Top investigators

Evan P Nadler, MD (1)  ·  Laura Stafman, MD (1)

Results publications

PMID 35391541